The SHP-2 inhibitor PHPS1 reversed the tumor-suppressive effects of UBE2D3 knockdown, while SHP-2 overexpression blocked the oncogenic effects of UBE2D3 overexpression. This evidence concerns the gene UBE2D3 and neoplasm.